Switching away from sulfonylureas in type 2 diabetes safety care
Part of Hormones & metabolism clinical trials.
This trial helps patients and their primary care team consider safer alternatives to sulfonylurea pills for type 2 diabetes. It may help reduce risks from sulfonylureas by improving how treatment changes are discussed and supported in routine care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years old or older
- You have type 2 diabetes (diagnosed on or before 12/31/2021)
- You currently take a sulfonylurea diabetes medicine (or medicines)
- You have seen a University Hospitals (UH) primary care doctor at least 2 times since 2021
- You do not have type 1 diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shared decision-making program for adults with type 2 diabetes. It aims to help you make informed choices about your diabetes care.
This study looks at two common diabetes pills (sulfonylureas and DPP4 inhibitors) when used together with metformin. It aims to find out which combination is more cost-effective for treating type 2 diabetes.
This trial tests whether managing your type 2 diabetes through online visits with a doctor can help you reach your blood sugar, cholesterol, and blood pressure goals. It's designed for people who haven't been able to meet these targets with their current care.
This trial tests a combination of three diabetes medicines (henagliflozin, retagliptin, and extended-release metformin) to see if they are safe and effective for Chinese adults with type 2 diabetes. You may join if you are newly diagnosed or have been taking one oral diabetes pill but need better blood sugar control.
This study tests a way to help older adults with type 2 diabetes who use insulin avoid dangerously low blood sugar. You would use a continuous glucose monitor and get support via email or internet to stay safe.
This trial tests a new medicine, UBT251, to see how well it lowers blood sugar in people with type 2 diabetes. It compares different doses to find the best one for you.
Hear when a new Type2diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.